Benchling vs Doxy.me

Side-by-side comparison of AI visibility scores, market position, and capabilities

Benchling leads in AI visibility (35 vs 33)

Benchling

EmergingAI Software

Life Sciences Software

Benchling is a life sciences R&D cloud platform with ~$200M+ ARR. Series E startup valued at ~$6.1B. Trusted by Pfizer, Genentech, and 1,000+ biotech/pharma teams. HQ: San Francisco.

AI VisibilityBeta
Overall Score
D35
Category Rank
#1 of 1
AI Consensus
59%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
37
Gemini
28

About

Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The company offers an integrated suite of tools including electronic lab notebooks (ELN), laboratory information management systems (LIMS), molecular biology design tools, and data management platforms, all connected in a unified cloud environment.

Full profile

Doxy.me

EmergingHealthcare

Telehealth

1M+ clinicians 150+ countries; 250K active providers; $50.2M revenue; acquired Telehealth.org/TeleMental Health Institute 2025; TIME HealthTech 2025; Ventures fund; telemedicine leader

AI VisibilityBeta
Overall Score
D33
Category Rank
#3 of 3
AI Consensus
54%
Trend
stable
Per Platform
ChatGPT
42
Perplexity
29
Gemini
42

About

Doxy.me was founded in 2013 by Brandon Welch in Hawaii with a mission to make telehealth accessible to every clinician and patient, regardless of technical sophistication or budget. The platform was built as a browser-based, zero-download video conferencing solution designed specifically for healthcare — requiring no app installation for patients and offering HIPAA-compliant video sessions out of the box. This simplicity-first approach drove grassroots adoption among solo practitioners and small clinics.\n\nDoxy.me's platform provides HIPAA-compliant video visits, virtual waiting rooms, patient intake forms, group rooms, and integrations with major EHR and practice management systems. Its free tier has been instrumental in driving adoption among independent clinicians who need compliant telehealth without enterprise procurement cycles. Premium tiers add advanced features including custom branding, staff accounts, and analytics. In 2025, Doxy.me acquired Telehealth.org and the TeleMental Health Institute, expanding its educational resources and professional training offerings.\n\nDoxy.me has grown to serve 1M+ clinicians across 150+ countries, with 250,000 active providers using the platform regularly. The company reported $50.2M in annual revenue and was recognized on TIME's HealthTech 2025 list. Its combination of clinical accessibility, global reach, and a freemium model that converts at scale positions Doxy.me as a foundational layer of the global telehealth infrastructure — particularly for solo and small-group practices that larger enterprise platforms overlook.

Full profile

AI Visibility Head-to-Head

35
Overall Score
33
#1
Category Rank
#3
59
AI Consensus
54
stable
Trend
stable
39
ChatGPT
42
37
Perplexity
29
28
Gemini
42
42
Claude
25
46
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.